Health Improvement Through Food and Lifestyle Intervention Based On Personalized Retail Advice
FLORA
1 other identifier
interventional
400
0 countries
N/A
Brief Summary
FLORA is a longitudinal intervention study with a randomized, parallel group design. Primary objective is to improve metabolic health through gut microbiota modulation by means of a retailer-driven personalized dietary intervention in a real-life setting. Four hundred Flemish pre-metabolic adults will be randomly divided into a control and treatment arm, each comprising 200 participants. The study period is divided into three phases: a four weeks characterization, a twelve weeks intervention, and a four weeks post-intervention phase. During the intervention phase, control participants' online Collect\&Go shopping carts are adjusted in accordance with Flemish food-based dietary guidelines. Based on the same guidelines, participants are provided with personalized dietary advice considering their usual dietary pattern and level of food literacy. In the treatment arm, a similar intervention will be applied using guidelines based on a microbiota modulation diet (MMD). During intervention, all participants can contact a dietician helpline for additional advice on study-related dietary issues. Over the five months, saliva and fecal samples will be collected on a regular basis, with an intensive sampling period of seven consecutive days at the end of each study phase. A GP consult consisting of a short medical exam, blood withdrawal and medical questionnaire takes place each month. Further, online questionnaires on lifestyle, health and well-being will be sent by e-mail and each five days, participants complete a food diary through their smartphone. Fecal, saliva, blood samples and meta-data will be analysed to detect changes in metabolic health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2019
CompletedFirst Posted
Study publicly available on registry
September 25, 2019
CompletedStudy Start
First participant enrolled
February 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedOctober 22, 2020
September 1, 2020
4 months
September 18, 2019
October 19, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Reduced waist circumference
Participants' waist circumference (cm) decreases during the study period
5 months
Reduced serum triglycerides
Participants' serum triglyceride level (mg/dL) decreases during the study period (blood sample analysis)
5 months
Reduced blood pressure
Participants' blood pressure (mm Hg) decreases during the study period
5 months
Elevated HDL-cholesterol
Participants' HDL-cholesterol levels (mg/dL) increase during the study period (blood sample analysis)
5 months
Reduced fasting plasma glucose
Participants' fasting plasma glucose levels decrease during the study period (blood sample analysis)
5 months
Study Arms (2)
Study arm
EXPERIMENTALDuring the three months intervention period, participants within this arm will do their groceries through the online Collect\&Go platform of Colruyt Group. Dietitians will adjust their shopping carts by changing food products by healthier alternative ones taking into account the Flemish food-based dietary guidelines. Based on participants' dietary pattern and level of food literacy, personalized dietary advice will be provided and a dietitian helpline will be available for further nutrition-related questions.
Control arm
NO INTERVENTIONDuring the three months intervention period, participants within this arm will do their groceries through the online Collect\&Go platform of Colruyt Group. Dietitians will adjust their shopping carts by changing food products by healthier alternative ones taking into account the guidelines from the newly developed microbiota modulation diet (MMD). Based on participants' dietary pattern and level of food literacy, personalized dietary advice will be provided and a dietitian helpline will be available for further nutrition-related questions.
Interventions
The Collect\&Go shopping carts of the 400 participants will be adapted by replacing food products by healthier alternative ones based on the Flemish food-based dietary guidelines and the microbiota modulation diet guidelines for the control and study arm respectively. Based on these guidelines, and the habitual dietary pattern and level of food literacy of the participant, personalized dietary advice will be provided. A dietitian helpline will be available for further nutritional issues as well.
Eligibility Criteria
You may qualify if:
- Willingness to participate to the study and to sign the informed consent (Dutch)
- Older than 18 years
- Diagnosed with pre-metabolic syndrome (diagnosed with central obesity \[waist circumference ≥80 cm for women and ≥94 cm for men\] and one of the following criteria: elevated blood pressure \[systolic ≥130 mm Hg, diastolic ≥85 mm Hg\], raised triglycerides \[\>150 mg/dL\], reduced HDL-cholesterol \[\<40 mg/dL in men, \<50 mg/dL in women\], or raised fasting plasma glucose \[≥100 mg/dL\]
- Residing in Belgium, no travels abroad planned longer than seven consecutive days during the five-months study period
- Willingness to follow dietary guidelines during the three-months intervention period
- Willingness to purchase bulk groceries primarily at Colruyt Group using the Collect\&Go platform during the five-months study period
- Access to a -20-18°C freezer
You may not qualify if:
- Chronic constipation (less than one defecation once a week)
- Gastro-intestinal surgery within the past 3 months
- Inflammatory bowel disease (IBD) or diverticulitis
- Irritable bowel syndrome (IBS)
- Any food allergy or food intolerance
- Metabolic syndrome
- Diabetes Mellitus Type 1 or Type 2
- Coeliac disease
- Pregnant women or women planning a pregnancy during the study period
- Lactating women
- Subjects on a specific diet (e.g. vegetarian/vegan diet, gluten-free diet, lactose-free diet, high-protein diet)
- Subjects being treated for hypertension or high cholesterol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SmartWithFoodlead
- Vlaams Instituut voor Biotechnologiecollaborator
- KU Leuvencollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2019
First Posted
September 25, 2019
Study Start
February 1, 2021
Primary Completion
June 1, 2021
Study Completion
July 1, 2021
Last Updated
October 22, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share